The nonstaff members of IAS–USA Metabolic Complications Guidelines Panel are volunteers and are not compensated for their role in overseeing the program. Listed below are the Metabolic Complications Guidelines Panel members and their financial relationships with commercial interests within the past 12 months from the date of disclosure.


Members:

Constance A. Benson, MD
Professor of Medicine
University of California San Diego
San Diego, California

Dr Benson has served on advisory and data monitoring boards for GlaxoSmithKline/ViiV Healthcare and received research grants awarded to her institution from Gilead Sciences, Inc. Her spouse has served as a consultant to CytoDyn, Gilead Sciences, Inc, Pfizer, and Vir Biotechnology; has received grant support from Gilead Sciences, Inc; and holds stock or stock options in Antiva Biosciences and CytoDyn. (Updated 04/29/19)

Andrew Carr, MD, MBBS
Professor of Medicine
University of New South Wales
Sydney, Australia

Dr Carr has no relevant financial affiliations to disclose. (Updated 12/11/17)

Judith S. Currier, MD
Professor of Medicine
University of California Los Angeles David Geffen School of Medicine
Los Angeles, California

Dr Currier has received grant support awarded to her institution from Theratechnologies. (Updated 03/28/19)

Michael P. Dubé, MD
Professor of Medicine
University of Southern California Keck School of Medicine
Los Angeles, California

Dr Dubé has no relevant financial affiliations to disclose. (Updated 12/11/17)

John G. Gerber, MD
Professor of Medicine and Pharmacology
University of Colorado Health Sciences Center
Denver, Colorado

Dr Gerber has no relevant financial affiliations to disclose. (Updated 12/11/17)

Steven K. Grinspoon, MD
Director, Program in Nutritional Metabolism
Professor, Harvard Medical School
Boston, Massachusetts

Dr Grinspoon has served as a consultant to Gilead Sciences, Inc, Merck & Co, Inc, Navidea, and Theratechnologies. He has received grants awarded to his institution from Gilead Sciences, Inc, Theratechnologies, Navidea, and Kowa Pharmaceuticals (Updated 04/14/17)

Carl Grunfeld, MD, PhD
Professor of Medicine
University of California San Francisco
San Francisco, California

Dr Grunfeld has no relevant financial affiliations to disclose. (Updated 12/11/17)

Donald P. Kotler, MD
Professor of Medicine
Columbia University
New York, New York

Dr Kotler has no relevant financial affiliations to disclose. (Updated 12/11/17)

Kathleen Mulligan, PhD
Associate Professor of Medicine
University of California San Francisco
San Francisco, California

Dr Mulligan has no relevant financial affiliations to disclose. (12/11/17)

William G. Powderly, MD
Professor of Medicine and Therapeutics
Mater University Hospital
Dublin, Ireland

Dr Powderly has no relevant financial affiliations to disclose. (Updated 12/11/17)

Michael S. Saag, MD
Professor of Medicine
University of Alabama at Birmingham
Birmingham, Alabama

Dr Saag has received research grants and support awarded to his institution from Gilead Sciences, Inc and ViiV Healthcare. (Updated 03/29/19)

Morris Schambelan, MD
Professor of Medicine
University of California San Francisco
San Francisco, California

Dr Schambelan has no relevant financial affiliations to disclose. (12/11/17)